CADLCandel Therapeutics, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $5.00 (+1.20% today)

Market Cap: $274.50M

P/E (TTM): -7.20

Relative Strength (RS%): 76

-31.0% from 52-week high

Back to Scanner

CADL

NASDAQRS 76Score 16

Candel Therapeutics, Inc.

HealthcareBiotechnology$274.50M
$5.00
+1.2% ($0.06)
-31.0% from 52W High
P/E (TTM)
-7.20
Fwd P/E
PEG
Analyst Upside
EPS Growth
Gross Margin
0.0%
ROE
-51.4%
D/E
0.04
Div Yield
0.0%
Avg Volume
910.4K

Price Chart

Key Levels

SMA 200
$5.50
SMA 50
$5.34
Price
$5.00
52W High
$7.25

Setup Radar

0/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst